CompletedNot Applicable

Interpretation Bias Modification Training for Social Anxiety Disorder

United States50 participantsStarted 2024-09-26

Plain-language summary

The overall goal of the current study is to develop and evaluate a computerized interpretation bias modification (IBM) training for treating social anxiety disorder (SAD). A key focus is placed on enhancing accessibility and efficacy of IBM for SAD by delivering it through a mobile platform, with three specific aims outlined. First, the current study aims to examine the efficacy of the IBM training in reducing social anxiety symptoms by comparing the pre-, post-, and follow-up assessments of the IBM group with a control group. Second, the current study aims to examine the effect of IBM on reducing participants' daily social anxiety symptoms using daily diary methodology. Third, the investigators also aim to evaluate the feasibility and acceptability of the IBM training. The investigators expect that at least 70% of participants will complete 4 or more of the six training sessions.

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of SAD based on the DIAMOND screening interview * Moderate or severe symptoms of SAD as assessed by the Liebowitz Social Anxiety Scale (LSAS score of \>= 30) * Ages 18-60 * English as a primary language * Possession of a mobile device for access to training and text message for daily diary Exclusion Criteria: * Self-report visual impairment that cannot be adjusted and will prevent them from clearly recognizing words and pictures on mobile screen * Self-reported history of a bipolar disorder or psychotic disorder as measured by Diagnostic History Scale * Current psychotherapy for SAD

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Brief Fear of Negative Evaluation (BFNE)

Timeframe: Pre-training (baseline); Post-training (approximately 1-2 days after completion of the 2-week intervention); 2-week follow-up (2 weeks after completion of the 2-week intervention)

Liebowitz Social Anxiety Scale- Self-report Version (LSAS-SR)

Timeframe: Pre-training (baseline); Post-training (approximately 1-2 days after completion of the 2-week intervention); 2-week follow-up (2 weeks after completion of the 2-week intervention)

Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND)

Timeframe: Pre-training (baseline); 2-week follow-up (2 weeks after completion of the 2-week intervention)

Trial details

NCT IDNCT07753538

SponsorUniversity of Wisconsin, Milwaukee

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-08

View on ClinicalTrials.gov More Social Anxiety Disorder (SAD) trials

Plain-language summary

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Brief Fear of Negative Evaluation (BFNE)

Timeframe: Pre-training (baseline); Post-training (approximately 1-2 days after completion of the 2-week intervention); 2-week follow-up (2 weeks after completion of the 2-week intervention)

Liebowitz Social Anxiety Scale- Self-report Version (LSAS-SR)

Timeframe: Pre-training (baseline); Post-training (approximately 1-2 days after completion of the 2-week intervention); 2-week follow-up (2 weeks after completion of the 2-week intervention)

Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND)

Timeframe: Pre-training (baseline); 2-week follow-up (2 weeks after completion of the 2-week intervention)